CD274 and undifferentiated pancreatic carcinoma: Genomic profiling of undifferentiated pancreatic sarcomatoid carcinoma suggests higher PD-L1 positivity on IHC in comparison to non-sarcomatoid carcinoma, with a small proportion (5%) being MSI-H/high tumor mutational burden.